Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350334
Max Phase: Preclinical
Molecular Formula: C32H38N6O7S
Molecular Weight: 650.76
Molecule Type: Small molecule
Associated Items:
ID: ALA3350334
Max Phase: Preclinical
Molecular Formula: C32H38N6O7S
Molecular Weight: 650.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS[C@H]1C[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)N(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(C)=O)C1
Standard InChI: InChI=1S/C32H38N6O7S/c1-18(39)35-26(13-20-16-34-23-11-7-6-10-22(20)23)32(45)38-17-21(46-2)14-27(38)31(44)37-25(15-28(40)41)30(43)36-24(29(33)42)12-19-8-4-3-5-9-19/h3-11,16,21,24-27,34H,12-15,17H2,1-2H3,(H2,33,42)(H,35,39)(H,36,43)(H,37,44)(H,40,41)/t21-,24-,25-,26-,27+/m0/s1
Standard InChI Key: YUOTWKOXZHMVQF-LRQPEXKUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 650.76 | Molecular Weight (Monoisotopic): 650.2523 | AlogP: 0.72 | #Rotatable Bonds: 14 |
Polar Surface Area: 203.79 | Molecular Species: ACID | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.97 | CX Basic pKa: | CX LogP: 0.17 | CX LogD: -3.00 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.15 | Np Likeness Score: -0.04 |
1. Kolodziej SA, Nikiforovich GV, Skeean R, Lignon MF, Martinez J, Marshall GR.. (1995) Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation., 38 (1): [PMID:7837225] [10.1021/jm00001a019] |
2. Kolodziej SA, Nikiforovich GV, Skeean R, Lignon MF, Martinez J, Marshall GR.. (1995) Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation., 38 (1): [PMID:7837225] [10.1021/jm00001a019] |
Source(1):